A top Democrat on the House antitrust panel sets sights on Big Pharma after wrapping up tech probe

Rep. Joe Neguse, D-Colo., wants the committee to examine the FTC's common approach to approving pharmaceutical mergers.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.